Study backs homocysteine and Alzheimer's link:
This article was originally published in Clinica
Executive Summary
Results from a study have provided more evidence to support the link between elevated blood levels of homocysteine and Alzheimer's disease (AD). US scientists at Boston University found that homocysteine levels that are greater than 14 mmol/litre doubled the chance of developing AD, and each 5 mmol/litre elevation increased the risk by 40%. The analysis also showed that people with consistently high levels of the marker were at highest risk for dementia and AD. The findings appear in The New England Journal of Medicine (February 14).
You may also be interested in...
Pink Sheet Podcast: Leqembi Spending, Woodcock’s Next Act, Pneumococcal Vaccine Development
Pink Sheet editors discuss Medicare spending projections for the Alzheimer’s treatment Leqembi, Janet Woodcock’s new post-FDA role, and ongoing preparations for new pneumococcal vaccines that will reach the market soon.
Investors Go Berserk For Viking, Putting It Top Of Q1 Winners
The top 10 biggest share price winners and losers in Q1 from Evaluate show the investor frenzy for obesity drugs continues, while companies with governance doubts see shareholders retreat.
EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications
Based on their experience with dealing with requests for access to documents over the past 12 years, EU regulators have proposed updating their guideline that provides for a harmonized approach to protecting personal data and business secrets in marketing authorization applications.